Detail akcie Brooks Aut online

Business Summary: Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Financial Summary: BRIEF: For the six months ended 31 March 2026, Azenta Inc revenues increased 1% to $293.4M. Net loss before extraordinary items increased from $26.9M to $162.2M. Revenues reflect Sample management solutions segment increase of 1% to $162.5M, Multiomics segment increase of 1% to $130.9M, China segment increase of 26% to $34.8M, United Kingdom segment increase of 30% to $20.4M, Rest of Europe segment increase of 6% to $52.4M.